You are here

A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLS

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Restless Legs Syndrome
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Idiopathic RLS

- Moderate to severe symptoms as indicated by an IRLS total score greater than or equal
to 10 and a severity at night score of greater than or equal to 4

- In a baseline polysomnography, patients had to have periodic leg movements during
sleep arousal index greater than 5/hour of total sleep time

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients suffering from seconadry RLS, due to causes such as iron deficiency or renal
disease, or suffering from secondary RLS while taking drugs suspected of causing
secondary forms of RLS

NCT00627003
Pfizer
Completed
A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLS

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Restless Legs Syndrome
NCT00625547
All Genders
18+
Years
Multiple Sites
Restless Legs Syndrome
NCT00676403
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now